No Need to Fear the EU Clinical Trial Directive

Many in the clinical trial industry were worried that the EU Directive would have a negative affect on the industry. In the latest study from the British Medical Journal as reported by Outsourcing-pharma.com, they reassure that so far there have been no negative repercussions, at least for Denmark. The main reason for the concern stemmed from worries that the amount of paper work that the Directive would require might result in public institutions being overwhelmed and unable to keep up. As the study reassures:

“academic researchers can match the demands for the good clinical practice quality standard that industry have adhered to for many years.”